FDAapproves nadofaragene firadenovec-vncg, the first gene therapy for adults with bladdercancer. BCSM
The adenovirus vector based gene therapy is indicated for adults with high-risk non-muscle invasive bladder cancer with carcinoma in situ with or without papillary tumors who are unresponsive to Bacillus Calmette-Guérin therapy.
Approval was based on a multicenter clinical study that included 98 evaluable patients with high-risk, BCG-unresponsive disease. Overall, 51% achieved a complete response with a disappearance of all signs of cancer on cystoscopy, biopsied tissue, and urine. The median duration of response was 9.7 months. Overall, 46% of responding patients remained in complete response for at least 1 year.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA approves first drug to delay type 1 diabetesNature Medicine explores the latest translational and clinical research news, with an immunotherapy that delays the onset of type 1 diabetes in high-risk children and adults.
Read more »
Houston approves first tax increment reinvestment zone under Mayor Sylvester Turner’s administrationHouston City Council on Wednesday voted to create a new Tax Increment Reinvestment Zone in the Texas Medical Center, to take advantage of the ongoing development of a sprawling biomedical research campus. Under a TIRZ, property tax revenues are frozen.
Read more »
San Antonio approves first batch of affordable housing bond fundingThe next round of funding, which the city’s housing officer has said he hopes will include more creative approaches to affordable housing, could open with a request for proposals as early as April.
Read more »
Randal Kolo Muani's first touch in the 2022 World Cup semifinal was his first France goalRandal Kolo Muani’s first goal for France could not have been more memorable, scoring the goal that clinched Les Bleus' trip to the World Cup final.
Read more »
Police Violence: It’s Expensive!As part of our '10 Biggest Austin News Stories' we spotlight the aftermath of APD's Eighth Street shootings.
Read more »
'Butterfly disease' makes the skin incredibly fragile, but a new gene therapy helps it healNicoletta Lanese is a staff writer for Live Science covering health and medicine, along with an assortment of biology, animal, environment and climate stories. She holds degrees in neuroscience and dance from the University of Florida and a graduate certificate in science communication from the University of California, Santa Cruz. Her work has appeared in The Scientist Magazine, Science News, The San Jose Mercury News and Mongabay, among other outlets.
Read more »